Outcome on 560 metastatic melanoma (MM) patients treated with pembrolizumab during the German Expanded Access Program (EAP) - Hassel, J.; Forschner, A.; Bluhm, L.; Heinzerling, Lucie; Zimmer, L.; Utikal, J.; Kaehler, K.; Schlaak, M.; Loquai, C.; Gutzmer, R.; Kieker, F.; Berking, C.; et al. (2016)
EVALuna2:33940